Takeda, Lilly Escape Already-Settled Diabetes Drug Claims
A California federal judge on Thursday tossed a proposed class action accusing Takeda Pharmaceuticals America Inc. and Eli Lilly and Co. of concealing health risks associated with the diabetes treatment Actos,...To view the full article, register now.
Already a subscriber? Click here to view full article